Raymond James Financial Services Advisors, Inc. Volitionrx LTD Transaction History

Raymond James Financial Services Advisors, Inc.

  • $66.3 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$2.98 - $3.48 $40,930 - $47,797
-13,735 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$3.01 - $3.78 $41,342 - $51,918
13,735 New
13,735 $45,000

Others Institutions Holding VNRX

# of Institutions
27
Shares Held
7.96M
Call Options Held
39K
Put Options Held
0
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email